Testing effectiveness (Phase 2)UnknownNCT02968303
What this trial is testing
Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy
Who this might be right for
Melanoma, Malignant, of Soft Parts
Radboud University Medical Center 200